Riad Mishlawi

Riad Mishlawi appears in our data through filings on Hikma Pharmaceuticals PLC shares, published by RNS (LSE). The record holds 10 filings, for trades running from 31 August 2023 to 22 September 2025.

Every open-market trade on record is a purchase: 2 purchases, and no sale. The totals do not cover 2 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 8 share grants. In 2025 alone, the filings show 1 purchase and no sales.

For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 50% of cases, with a median move of -1.2%. These figures describe past trades and do not predict future prices.

Most recently, on 23 September 2025, the filings show a share grant worth €31k in Hikma Pharmaceuticals PLC. The last purchase on record was published on 4 March 2025, which is 615 days ago. The median gap between a trade and its publication by RNS (LSE) is 2 days. The legal deadline for notifying a trade is three business days (UK MAR). These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.